FDA Inspection
Llorens Pharmaceuticals International Division, Inc.Llorens Pharmaceuticals International Division, Inc. – FDA Inspection, May 15, 2025
Record Details
This FDA Inspection record concerns Llorens Pharmaceuticals International Division, Inc., with an inspection on May 15, 2025, issued by the Florida District Office, covering human drugs.
- Inspection Date
- May 15, 2025
- Product Type
- Human Drugs
View Company Profile
ID · b049b970-3f0c-45de-85b6-2453d1dbb9ef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1258728
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)(3)Valid stability test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Llorens Pharmaceuticals International Division, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2025 | VAI | Florida District Office | Food Composition, Standards, Labeling, and Economics |
| March 11, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2019 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| July 12, 2016 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| May 22, 2012 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Llorens Pharmaceuticals International Division, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.